For the Inventor, By the Inventor

Enter assignee name

Mountain View, CA, United States of America

Alexza Pharmaceuticals, Inc.

USPTO Granted Patents = 114

% Expired Patents = 60.5

CIPO Patents = 7

EPO Patents = 16

Trademarks = 4

Forward Citations = 5,971

Loading Chart...

Loading Chart...

51 inventors (with patents filed for the assignee):

Joshua D Rabinowitz (84 out of 130 patents)

Alejandro C Zaffaroni (70 out of 122 patents)

Ron L Hale (28 out of 42 patents)

4. Martin J Wensley (25 out of 34 patents)

5. Daniel J Myers (24 out of 25 patents)

6. Peter Lloyd (19 out of 24 patents)

7. Craig C Hodges (15 out of 17 patents)

8. Dennis Solas (12 out of 47 patents)

9. Soonho Song (12 out of 12 patents)

10. Reynaldo J Quintana (11 out of 25 patents)

11. Amy Tsai Lu (10 out of 13 patents)

12. Curtis Peter Tom (9 out of 29 patents)

13. Daniel Mufson (9 out of 11 patents)

14. Mingzu Lei (9 out of 9 patents)

15. Daniel David Rogers (9 out of 16 patents)

Core Competencies:

Aerosol Forming Device

Drug Delivery Device

Inhalation Therapy

Nicotine Salt

Heating Unit

Drug Condensation Aerosols

Exothermic Reactions

Antipsychotics Delivery

Thermal Aerosol Condensation

Respiratory Drugs

Vaporizing Compounds

Multiple Dose Devices

114 patents: Sort by Forward Citations

1. 12214119 - Electrical condensation aerosol device (2025-02-04),

2. 12214118 - Electrical condensation aerosol device (2025-02-04),

3. 12138383 - Heating unit for use in a drug delivery device (2024-11-12),

4. 12133915 - Method of treating epilepsy (2024-11-05),

5. 11839714 - Heat units using a solid fuel capable of undergoing an exothermic metal oxidation-reduction reaction propagated without an igniter (2023-12-12),

6. 11717479 - Method of treating epilepsy (2023-08-08),

7. 11642473 - Heating unit for use in a drug delivery device (2023-05-09),

8. 11511054 - Use of antistatic materials in the airway for thermal aerosol condensation process (2022-11-29),

9. 11484668 - Heat units using a solid fuel capable of undergoing an exothermic metal oxidation-reduction reaction propagated without an igniter (2022-11-01),

10. 11458130 - Nicotine salt with meta-salicylic acid and applications therein (2022-10-04),

11. 11241383 - Method of treating epilepsy (2022-02-08),

12. 11065400 - Aerosol forming device for use in inhalation therapy (2021-07-20),

13. 10786635 - Heat units using a solid fuel capable of undergoing an exothermic metal oxidation-reduction reaction propagated without an igniter (2020-09-29),

14. 10625033 - Heating unit for use in a drug delivery device (2020-04-21),

15. 10350157 - Drug condensation aerosols and kits (2019-07-16),

Company Overview

Alexza Pharmaceuticals, Inc., based in Mountain View, California, specializes in the development and commercialization of innovative aerosol drug delivery systems. The company focuses on creating advanced inhalation therapies, particularly for delivering medications such as antipsychotics and nicotine salts. Their core technologies include aerosol forming devices and heating units that facilitate drug condensation through exothermic reactions, enhancing the efficiency and effectiveness of therapeutic delivery via inhalation.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

114 Patents

#31 in Mountain View, CA

#760 in California

#3,363 in US

#6,937 in the World

Mountain View, CA, United States of America

Alexza Pharmaceuticals, Inc.

Forward Citations = 5,971

51 inventors:

Joshua D Rabinowitz (84 out of 130 patents)

Alejandro C Zaffaroni (70 out of 122 patents)

Ron L Hale (28 out of 42 patents)

4. Martin J Wensley (25 out of 34 patents)

5. Daniel J Myers (24 out of 25 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alexza Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/alexza-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…